TrialBlood2009

Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors.

John Koreth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.